MAPT and Alzheimer disease: Importantly, we also found that plasma phosphorylated tau (p-tau) isoforms (p-tau181, p-tau217, and p-tau231) were significantly elevated in patients with AD and MCI compared with controls (Figure 3), and that these changes broadly paralleled the tau-PET findings (Figure 5).